scholarly journals Homozygosity mapping identified a novel protein truncating mutation (p.Ser100Leufs*24) of the BBS9 gene in a consanguineous Pakistani family with Bardet Biedl syndrome

2016 ◽  
Vol 17 (1) ◽  
Author(s):  
Muzammil Ahmad Khan ◽  
Sumitra Mohan ◽  
Muhammad Zubair ◽  
Christian Windpassinger
2020 ◽  
Vol 8 (2) ◽  
Author(s):  
Muhammad Z. Ali ◽  
Jasmin Blatterer ◽  
Muzammil A. Khan ◽  
Erich Schaflinger ◽  
Erwin Petek ◽  
...  

Author(s):  
Muhammad Muzammal ◽  
Muhammad Zeeshan Ali ◽  
Beatrice Brugger ◽  
Jasmin Blatterer ◽  
Safeer Ahmad ◽  
...  

Abstract Background L-2-hydroxyglutaric aciduria (L2HGA) is a rare neurometabolic disorder that occurs due to accumulation of L-2-hydroxyglutaric acid in the cerebrospinal fluid (CSF), plasma and urine. The clinical manifestation of L2HGA includes intellectual disability, cerebellar ataxia, epilepsy, speech problems and macrocephaly. Methods In the present study, we ascertained a multigenerational consanguineous Pakistani family with 5 affected individuals. Clinical studies were performed through biochemical tests and brain CT scan. Locus mapping was carried out through genome-wide SNP genotyping, whole exome sequencing and Sanger sequencing. For in silico studies protein structural modeling and docking was done using I-TASSER, Cluspro and AutoDock VINA tools. Results Affected individuals presented with cognitive impairment, gait disturbance, speech difficulties and psychomotor delay. Radiologic analysis of a male patient revealed leukoaraiosis with hypoattenuation of cerebral white matter, suggestive of hypomyelination. Homozygosity mapping in this family revealed a linkage region on chromosome 14 between markers rs2039791 and rs781354. Subsequent whole exome analysis identified a novel frameshift mutation NM_024884.3:c.180delG, p.(Ala62Profs*24) in the second exon of L2HGDH. Sanger sequencing confirmed segregation of this mutation with the disease phenotype. The identification of the most N-terminal loss of function mutation published thus far further expands the mutational spectrum of L2HGDH.


2006 ◽  
Vol 103 (16) ◽  
pp. 6287-6292 ◽  
Author(s):  
A. P. Chiang ◽  
J. S. Beck ◽  
H.-J. Yen ◽  
M. K. Tayeh ◽  
T. E. Scheetz ◽  
...  

Gene ◽  
2013 ◽  
Vol 519 (1) ◽  
pp. 177-181 ◽  
Author(s):  
Zehra Agha ◽  
Zafar Iqbal ◽  
Maleeha Azam ◽  
Lies H. Hoefsloot ◽  
Hans van Bokhoven ◽  
...  

2006 ◽  
Vol 14 (11) ◽  
pp. 1195-1203 ◽  
Author(s):  
Virginie Laurier ◽  
Corinne Stoetzel ◽  
Jean Muller ◽  
Christelle Thibault ◽  
Sandra Corbani ◽  
...  

2009 ◽  
Vol 47 (4) ◽  
pp. 236-241 ◽  
Author(s):  
L. Abu Safieh ◽  
M. A. Aldahmesh ◽  
H. Shamseldin ◽  
M. Hashem ◽  
R. Shaheen ◽  
...  

2017 ◽  
Vol 55 (3) ◽  
pp. 189-197 ◽  
Author(s):  
Esra Yıldız Bölükbaşı ◽  
Sara Mumtaz ◽  
Muhammad Afzal ◽  
Ute Woehlbier ◽  
Sajid Malik ◽  
...  

BackgroundBardet-Biedl syndrome (BBS) is a ciliopathy with extensive phenotypic variability and genetic heterogeneity. We aimed to discover the gene mutated in a consanguineous kindred with multiple cases of a BBS phenotype.MethodsSNP genotype data were used for linkage analysis and exome sequencing to identify mutations. Modelling and in silico analysis were performed to predict mutation severity.ResultsPatients had postaxial polydactyly plus variable other clinical features including rod-cone dystrophy, obesity, intellectual disability, renal malformation, developmental delay, dental anomalies, speech disorder and enlarged fatty liver. The 4.57 Mb disease locus harboured homozygous, truncating CEP19 c.194_195insA (p.Tyr65*) mutation. We also found glioma-associated oncogene homolog 1(GLI1) c.820G>C (p.Gly274Arg) in the homozygous state in most patients. In silico modelling strongly suggests that it is damaging. Also, different combinations of four possible modifier alleles in BBS-related genes were detected. Two are known modifier alleles for BBS, splicing variant CCDC28B c.330C>T and missense MKKS/BBS6 p.Ile339Val, and the others are C8ORF37/BBS21 p.Ala178Val and TMEM67/BBS14 modifier p.Asp799Asp. Some patients carry all those five known/possible modifier alleles. Such variants are highly significantly more abundant in our patients than in a control group.ConclusionCEP19 encodes a centrosomal and ciliary protein, as all BBS genes do. Another truncating mutation p.Arg82* has been reported as responsible for morbid obesity in a family; however, in the family we present, not all homozygotes are obese, although some are severely obese. The variant in GLI1, encoding a transcription factor that localises to the primary cilium and nucleus and is a mediator of the sonic hedgehog pathway, possibly exacerbates disease severity when in the homozygous state.


2020 ◽  
Vol 29 (1) ◽  
pp. 17-23 ◽  
Author(s):  
Amir Hayat ◽  
Atif Ahmad Khan ◽  
Abdur Rauf ◽  
Saad Ullah Khan ◽  
Shabir Hussain ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document